These multifaceted metabolic effects position dual GLP-1/GIP receptor agonists as superior therapeutic candidates for MASLD, especially in patients with coexisting obesity and T2DM, where dysregulated glucose and lipid metabolism drive the progression of the disease
GLP-1 agonists as a class offer substantial benefits, including improved glycemic control, weight reduction, and cardiovascular protection, that millions of Americans have come to rely on, and semaglutide brands such as Ozempic and Wegovy have emerged as the drugs of choice for most patients
Liver-specific model for Plasmodium falciparum The liver-iPfa model is reconstructed from the published iPfa genome-scale model for P
How to Choose Between Glycolic Acid and Salicylic Acid Choosing between glycolic acid and salicylic acid depends on your skin care needs
Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells
Weight loss doctors emphasize that Wegovy, like all GLP1 weight loss shots, requires ongoing medical supervision and should be part of a comprehensive weight management program